Novartis | Ventes



Sales Changement Date
AbbVie USD 15.42B 2.08B 2025-06
Alcon AG USD 2.45B 30M 2025-03
Almirall EUR 275M 9.6M 2025-06
Amgen USD 9.18B 1.03B 2025-06
AstraZeneca USD 14.46B 867M 2025-06
Autolus Therapeutics Ltd 2.1M 2.07M 2025-03
Bayer EUR 10.74B 3B 2025-06
Biogen USD 2.6B 170M 2025-06
Bristol-Myers Squibb USD 12.27B 1.07B 2025-06
Eli Lilly USD 15.56B 2.83B 2025-06
Fresenius EUR 5.58B 70M 2025-06
Fresenius Medical Care EUR 4.79B 90M 2025-06
Galapagos EUR 70.17M 4.81M 2025-06
Genmab DKK 5.28B 59.13B 2025-03
Gilead Sciences USD 7.1B 430M 2025-06
GlaxoSmithKline GBP 7.99B 470M 2025-06
GRIFOLS EUR 1.89B 100M 2025-06
Hikma Pharmaceutical USD 1.59B 18M 2024-12
J&J USD 23.74B 1.85B 2025-06
Lonza CHF 3.58B 63M 2025-06
Merck EUR 4.43B 850M 2025-06
Merck USD 15.81B 280M 2025-06
Novartis USD 14.05B 821M 2025-06
Novartis USD 13.56B 386M 2024-12
Novo Nordisk 76.86B 1.23B 2025-06
Orion EUR 416.5M 61.9M 2025-06
Pfizer USD 14.7B 980M 2025-06
Philips EUR 4.34B 241M 2025-06
Recordati EUR 643.15M 36.81M 2025-06
Regeneron Pharmaceuticals USD 3.68B 650M 2025-06
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 9.99B 90M 2025-06
UCB EUR 3.49B 129M 2025-06


Novartis Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.